ATRA · Atara Biotherapeutics Inc
United States · RS rating 87 · As of 2026-10-14
| Price | 9.56 USD |
|---|---|
| 1-day change | +2.7% |
| RS rating (overall / 1M / 3M / 12M) | 87 / 77 / 85 / 19 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 30 / 40 / 27 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -10.3% |
| Sales growth Q/Q | -53.8% |
| Distance from 52-week high | +47.1% |
| Market cap (USD) | $40.1M |